Decreased hexosamine biosynthesis in GH-deficient dwarf rat muscle. Reversal with GH, but not IGF-I, therapy

American Journal of Physiology - Endocrinology and Metabolism

Volumn 276, Issue 3 39-3, 1999, Pages

  Robinson, Katherine A ^a   Willi, Steven M ^a   Bingel, Sarah ^b   Buse, Maria G ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Growth hormone induced insulin resistance; L glutamine:D fructose 6 phosphate amidotransferase activity in muscle and liver; Regulation of hexosamine biosynthesis by growth hormone in muscle; UDP N acetyl hexosamine concentration in muscle and liver

Indexed keywords

6 PHOSPHOFRUCTOKINASE; GROWTH HORMONE; HEXOSAMINE; HUMAN GROWTH HORMONE; SOMATOMEDIN C;

ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CARBOHYDRATE SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GROWTH HORMONE DEFICIENCY; GROWTH RATE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; MUSCLE METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032896744     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1999.276.3.e435     Document Type: Article

References (32)

1. Argente, J., J. A. Chowen, P. Zeitler, D. K. Clifton, and R. A. Steiner. Sexual dimorphism of growth hormone-releasing hormone and somatostatin gene expression in the hypothalamus of the rat during development. Endocrinology 128: 2369-2375, 1991.
2. Argetsinger, L. S., G. W. Hsu, M. G. Myers, Jr., N. Billestrup, M. F. White, and C. Carter-Su. Growth hormone, interferon-γ and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1. J. Biol. Chem. 270: 14685-14692, 1995.
3. Bak, J. F., N. Møller, and O. Schmitz. Effects of growth hormone on fuel utilization and muscle glycogen synthase activity in normal humans. Am. J. Physiol. 260 (Endocrinol. Metab. 23): E736-E742, 1991.
4. Baron, A. D., J.-S. Zhu, H. Weldon, L. Maianu, and W. T. Garvey. Glucosamine induces insulin resistance in vivo by affecting GLUT4 translocation in skeletal muscle. Implications for glucose toxicity. J. Clin. Invest. 96: 2792-2801, 1995.
5. Brain, C. E., P. Chomczynski, T. R. Downs, and L. A. Frohman. Impaired generation of cyclic adenosine 3′,5′-monophosphate in a somatomammotroph cell line derived from dwarf (dw) rat anterior pituitaries. Endocrinology 129: 3410-3416, 1991.
6. Buse, M. G., K. A. Robinson, T. W. Gettys, E. G. McMahon, and E. Gulve. Increased activity of the hexosamine synthesis pathway in muscles of insulin-resistant ob / ob mice. Am. J. Physiol. 272 (Endocrinol Metab. 35): E1080-E1088, 1997.
7. Buse, M. G., K. A. Robinson, B. A. Marshall, and M. Mueckler. Differential effects of GLUT1 or GLUT4 overexpression on hexosamine biosynthesis by muscles of transgenic mice. J. Biol. Chem. 271: 23197-23202, 1996.
8. Charlton, H. M., R. G. Clark, I. C. A. F. Robinson, A. E. Porter Goff, B. S. Cox, C. Bugnon, and B. A. Bloch. Growth hormone-deficient dwarfism in the rat: a new mutation. J. Endocrinol. 119: 51-58, 1988.
9. Daniels, M. C., T. P. Ciaraldi, S. Nikoulina, R. R. Henry, and D.A. McClain. Glutamine: fructose-6-phosphate amidotransferase activity in cultured human skeletal muscle cells. Relationship to glucose disposal rate in control and non-insulin-dependent diabetes mellitus subjects and regulation by glucose and insulin. J. Clin. Invest. 97: 1235-1241, 1996.
10. DeFronzo, R. A., and D. C. Simonson. Glucose toxicity. In: Advances in Endocrinology and Metabolism. St. Louis, MO: Mosby, 1992, vol. 3, p. 1-53.
11. Eriksson, H., M. Ridderstrale, and H. Tornquist. Tyrosine phosphorylation of the growth hormone (GH) receptor and janus tyrosine kinase-2 is involved in the insulin-like actions of GH in primary rat adipocytes. Endocrinology 136: 5093-5101, 1995.
12. Grønbsek, H., P. Volmers, S. F. Bjørn, R. Østerby, H. Ørskov, and A. Flyvbjerg. Effect of GH/IGF-1 deficiency on long-term renal changes and urinary albumin excretion in diabetic dwarf rats. Am. J. Physiol. 272 (Endocrinol. Metab. 35): E918-E924, 1997.
13. Hawkins, M., I. Angelov, R. Liu, N. Barzilai, and L. Rossetti. The tissue concentration of UDP-N-acetylglucosamine modulates the stimulatory effect of insulin on skeletal muscle glucose uptake. J. Biol. Chem. 272: 4889-4895, 1997.
14. Hawkins, M., N. Barzilai, R. Liu, M. Hu, W. Chen, and L. Rossetti. Role of the glucosamine pathway in fat-induced insulin resistance. J. Clin. Invest. 99: 2173-2182, 1997.
15. Herbert, L., M. Daniels, J. Zhou, E. Crook, R. Turner, S. Simmons, J. Neidigh, J.-S. Zhou, A. Baron, and D. McClain. Overexpression of glutamine: fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance. J. Clin. Invest. 98: 930-936, 1996.
16. Kolm-Litty, V., U. Sauer, A. Nerlich, R. Lehmann, and E. D. Schleicher. High glucose-induced transforming growth factor β1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J. Clin. Invest. 101: 160-169, 1998.
17. Legraverend, C., A. Mode, T. Wells, I. Robinson, and J.-A. Gustafsson. Hepatic steroid hydroxylating enzymes are controlled by the sexually dimorphic pattern of growth hormone secretion in normal and dwarf rats. FASEB J. 6: 711-718, 1992.
18. Lemmey, A. B., J. Glassford, H. C. Flicksmith, J. M. P. Holly, and J. M. Pell. Differential regulation of tissue insulin-like growth factor-binding protein (IGFBP) -3, IGF-1 and IGF type 1 receptor mRNA levels, and serum IGF-1 and IGFBP concentrations by growth hormone and IGF-1. J. Endocrinol. 154: 319-328, 1997.
19. Marshall, S., V. Bacote, and R. R. Traxinger. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system: role of hexosamine biosynthesis in the induction of insulin resistance. J. Biol. Chem. 266: 4706-4712, 1991.
20. McClain, D. A., and E. D. Crook. Hexosamine and insulin resistance. Diabetes 45: 1003-1009, 1996.
21. Merimee, T. J., P. Felig, E. Marliss, S. E. Fineberg, and G. G. Cahill, Jr. Glucose and lipid homeostasis in the absence of human GH. J. Clin. Invest. 50: 574-582, 1971.
22. Napoli, R. A., A. Cittadini, J. C. Chow, M. F. Hirshman, R. J. Smith, P. S. Douglas, and E. S. Horton. Chronic growth hormone treatment in normal rats reduces post-prandial skeletal muscle GLUT1 content, but not glucose transport or GLUT4 expression and localization. Biochem. J. 315: 959-963, 1996.
23. Nerlich, A. G., U. Sauer, V. Kolm-Litty, E. Wagner, M. Koch, and E. D. Schleicher. Expression of glutamine: fructose-6-phosphate amidotransferase in human tissues. Evidence for high variability and distinct regulation in diabetes. Diabetes 47: 170-178, 1998.
24. Richards, T. C., and O. Greengard. Distribution of glutamine hexosephosphate amidotransferase in rat tissue: changes with state of differentiation. Biochem. Biophys. Acta 304: 842-850, 1973.
25. Robinson, K. A., D. A. Sens, and M. G. Buse. Pre-exposure to glucosamine induces insulin resistance of glucose transport and glycogen synthesis in isolated rat skeletal muscles. Study of mechanisms in muscles and in rat-1 fibroblasts overexpressing the human insulin receptor. Diabetes 42: 1333-1346, 1993.
26. Robinson, K. A., M. L. Weinstein, G. E. Lindenmayer, and M. G. Buse. Effects of diabetes and hyperglycemia on the hexosamine synthesis pathway in rat skeletal muscle. Diabetes 44: 1438-1446, 1995.
27. Rossetti, L., M. Hawkins, W. Chen, J. Gindi, and N. Barzilai. In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats. J. Clin. Invest. 96: 132-140, 1995.
28. Scottner, A., R. G. Clark, L. Fryklund, and I. C. A. F. Robinson. Growth responses in a mutant dwarf rat to human growth hormone and recombinant human insulin-like growth factor I. Endocrinology 124: 2519-2526, 1989.
29. Smith, T. R., J. S. Elmendorf, T. S. David, and J. Turinsky. Growth hormone-induced insulin resistance: role of the insulin receptor, IRS-1, GLUT-1, and GLUT-4. Am. J. Physiol. 272 (Endocrinol. Metab. 35): E1071-E1079, 1997.
30. Weaver, J. U., J. P. Monson, K. Noonan, W. G. John, A. Edwards, K. A. Evans, and J. Cunningham. The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity and cardiovascular risk factors in hypopituitary adults. J. Clin. Endocrinol. Metab. 80: 153-159, 1995.
31. Wilson, V. J., M. Rattray, C. R. Thomas, B. H. Moreland, and D. Schulster. Growth hormone increases IGF-1, collagen I and collagen III gene expression in dwarf rat skeletal muscle. Mol. Cell. Endocrinol. 115: 187-197, 1995.
32. Wright, N. M., J. Renault, B. Hollis, N. H. Bell, and L. L. Key. Effect of growth hormone on bone: bone mineral density, trabecular bone volume, and alkaline phosphatase improve or are restored in the dwarf rat treated with growth hormone. J. Bone Miner. Res. 10: 127-131, 1995.